Literature DB >> 34581905

Indian Outpatients with Idiopathic Chronic Pancreatitis Have Catastrophic Healthcare Expenditure, Malnutrition, Anxiety/Depression and Work-Impairment.

Pankaj Singh1, Bidhan Chakraborty1, Sujit Sarkhel2, Sukanta Ray3, Partha Sarathi Patra1, Kshaunish Das4.   

Abstract

INTRODUCTION: There is paucity of data regarding economic burden, employment affection, psychological and nutritional status of CP patients, of non-alcoholic etiology, especially during their periods of stable disease, i.e., without any complications and/or recent endoscopic/surgical interventions.
METHODS: In a prospective cohort study, conducted in outpatient clinic of a tertiary-care hospital, 66 consecutive adults with Idiopathic CP (± diabetes) and 152 matched (by age, socioeconomic status and monthly income) healthy controls were assessed for: (1) healthcare expenses in previous month by recall (catastrophic if > 40% of income); (2) nutritional status by anthropometry and food frequency questionnaire; (3) psychological status by Hospital Anxiety and Depression Scale (HADS); and (4) work-impairment by work productivity and activity impairment questionnaire: general health (WPAI-GH). CP patients were again reassessed for the above parameters after 6 and 12 month, respectively.
RESULTS: Seventy-six percent CP patients (vis-à-vis 0% controls) had catastrophic healthcare expenditure. Forty-nine percent of CP patients(vis-à-vis 0% controls) met their healthcare expenses by either selling assets or obtaining loans at high-interest or from charitable donations. CP patients had lower BMI, were more likely to be malnourished and had a lower calorie intake vis-à-vis controls (median (IQR) recommended daily allowance (RDA): 71(19)% vs 97(23)%; [p < 0.0001]). Their median HADS Anxiety and depression scores were significantly higher than controls. Thirty-one (47%) CP patients were employed vis-a-vis 102 (67%) controls (p = 0.006); they had significantly higher work impairment. After one year, there was improvement in some of these above parameters in CP patients.
CONCLUSION: Idiopathic CP outpatients had catastrophic healthcare expenditure, malnutrition, abnormal psychological scores and work-impairment vis-à-vis healthy controls. Some of these parameters improved on follow-up.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Pain; Poverty; Quality-of-life; Surgery

Mesh:

Year:  2021        PMID: 34581905     DOI: 10.1007/s10620-021-07255-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  5 in total

Review 1.  A review of methods to measure health-related productivity loss.

Authors:  Soeren Mattke; Aruna Balakrishnan; Giacomo Bergamo; Sydne J Newberry
Journal:  Am J Manag Care       Date:  2007-04       Impact factor: 2.229

2.  Anthropometric, biochemical, clinical and dietary assessment for malnutrition in south Indian patients with chronic pancreatitis.

Authors:  James Tinju; Shine Reshmi; Gopalakrishna Rajesh; Vallath Balakrishnan
Journal:  Trop Gastroenterol       Date:  2010 Oct-Dec

3.  Trial-based cost-effectiveness analysis comparing surgical and endoscopic drainage in patients with obstructive chronic pancreatitis.

Authors:  Philippe Laramée; David Wonderling; Djuna L Cahen; Marcel G Dijkgraaf; Dirk J Gouma; Marco J Bruno; Stephen P Pereira
Journal:  BMJ Open       Date:  2013-09-23       Impact factor: 2.692

4.  A Retrospective Administrative Database Analysis of Suicide Attempts and Completed Suicide in Patients With Chronic Pancreatitis.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Chung-Y Hsu; Chia-Hung Kao
Journal:  Front Psychiatry       Date:  2018-04-18       Impact factor: 4.157

5.  Effect of health insurance program for the poor on out-of-pocket inpatient care cost in India: evidence from a nationally representative cross-sectional survey.

Authors:  Shyamkumar Sriram; M Mahmud Khan
Journal:  BMC Health Serv Res       Date:  2020-09-07       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.